Firstly, problems related to the identification of the denominator: not possible to identify patients who had started insulin therapy (3 areas), patients referred for the first time to the secondary care level (2 areas), and patients referred to secondary care for suspected cancer (1 area). The gene discussed is INS; the disease is cancer.